What are the most relevant achievements that SPIN has accomplished in the last 3 years?
How have outcomes in patients with psoriasis changed with respect to the past and what can be expected in the future?
How can health care professionals help to more effectively allocate resources for management of psoriasis?
What is your overall philosophy and approach as President-elect of the SPIN Scientific Committee?
What major goals would you like to achieve for the next 3 years and beyond?
Can registries contribute to better understanding of the epidemiology of psoriasis?
What disease and treatment areas do you plan to address during your leadership?
What is the importance of guidelines in defining treatment goals of major inflammatory skin diseases?
How can the results of current research be translated into routine clinical practice?
The scientific programme of the meeting was drafted by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology, in collaboration with the SPIN Scientific Committee. How did this process work?
What are some of the new concepts presented at SPIN 2019?
Any comments on the “How to Manage” sessions in which clinicians from around the world shared their real-life experiences?